Page 4 of 9
Which patients were included in this study?
Studies have a list of requirements for patients who can enrol (inclusion criteria) and
those who can’t (exclusion criteria). For this study, the main inclusion and exclusion
criteria are listed below.
Men and women with SLE were included in the study if they:
• Were at least 18 years old.
• Tested positive for the presence of autoantibodies before starting the
study.
• Were on stable regular SLE treatment before starting the study.
Men and women were excluded from the study if they had:
• Received treatment with belimumab before starting the study.
• Received any other treatment(s) that affected B cells.
• Been treated for severe kidney disease caused by SLE or inflammation
of the kidneys within three months before starting the study
treatment.
• Abnormalities of the nervous system caused by SLE (such as seizures,
psychosis) requiring treatment before starting the study.
• Received treatment for an acute or chronic infection within two
months of starting the study.
• Other disease(s) or taken medicine(s) that the study doctor thought
would affect the results of the study.
Overall, 4003 patients received at least one dose of the study medicine. The study
included 302 (8%) men and 3701 (92%) women. The average age was 41 years. The
youngest patient was 17 years old and the oldest patient was 86 years old.